ALOPM — Oncodesign Precision Medicine Opm SA Income Statement
0.000.00%
Last trade - 00:00- €7.16m
- €9.47m
- €0.21m
Annual income statement for Oncodesign Precision Medicine Opm SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4.41 | 3.83 | 7.98 | 1.07 | 0.207 |
| Cost of Revenue | |||||
| Gross Profit | 4.5 | 3.92 | 8.01 | 1.4 | 0.219 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 5.81 | 7.56 | 9.59 | 11 | 8.03 |
| Operating Profit | -1.4 | -3.73 | -1.61 | -9.94 | -7.82 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.69 | -4.08 | -1.72 | -9.85 | -8.31 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.154 | -2.94 | -0.231 | -8.09 | -7.21 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.154 | -2.94 | -0.231 | -8.09 | -7.21 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.154 | -2.94 | -0.231 | -8.09 | -7.21 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.454 | -0.43 | -0.014 | -0.487 | -0.385 |